OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
about
Oxidation of marine omega-3 supplements and human healthTriglyceride-rich lipoproteins as a causal factor for cardiovascular diseaseOmega-3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular diseaseNutraceuticals and Bioactive Components from Fish for Dyslipidemia and Cardiovascular Risk ReductionOmega-3 Polyunsaturated Fatty Acids: The Way Forward in Times of Mixed EvidenceOmega-3 supplements and cardiovascular diseasesOmega-3s and cardiovascular health.Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits?The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS)Progressing Insights into the Role of Dietary Fats in the Prevention of Cardiovascular DiseaseNutrient reference value: non-communicable disease endpoints--a conference reportIntegrative Therapies and Cardiovascular Disease in the Breast Cancer Population: A Review, Part 2Overview of prescription omega-3 fatty acid products for hypertriglyceridemiaEffect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in patients with a previous myocardial infarction: a randomised controlled trialA Comparative Overview of Prescription Omega-3 Fatty Acid ProductsDietary supplements and disease prevention - a global overview.Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial.Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled studyDo omega-3 polyunsaturated Fatty acids prevent cardiovascular disease? A review of the randomized clinical trials.Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN(®) REVEAL Trial.Polyunsaturated fatty acids and peripheral artery disease.Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: a systematic review.Fatty acid metabolism in carriers of apolipoprotein E epsilon 4 allele: is it contributing to higher risk of cognitive decline and coronary heart disease?Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical TrialRecent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?Krill oil for cardiovascular risk prevention: is it for real?Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials.Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work?Omega-3 fatty acids EPA and DHA: health benefits throughout life.Exploratory analysis on the use of statins with or without n-3 PUFA and major events in patients discharged for acute myocardial infarction: an observational retrospective study.Acute administration of n-3 rich triglyceride emulsions provides cardioprotection in murine models after ischemia-reperfusionHerbal, vitamin, and mineral supplement use in patients enrolled in a cardiac rehabilitation program.Predictors of omega-3 index in patients with acute myocardial infarction.Effect of omega-3 fatty acid supplementation on cancer incidence, non-vascular death, and total mortality: a meta-analysis of randomized controlled trials.Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosisn-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes.Retrospective Case Series of Patients with Diabetes or Prediabetes Who Were Switched from Omega-3-Acid Ethyl Esters to Icosapent EthylThe effects of supplementation with omega-3 polyunsaturated Fatty acids on cardiac rhythm: anti-arrhythmic, pro-arrhythmic, both or neither? It depends…Omega-3 Fatty acids: anti-arrhythmic, pro-arrhythmic, or both?Epidemiology's continuing contribution to public health: The power of "Then and Now".
P2860
Q21284850-E05958C6-BBBF-445C-BED2-D9E877DC5055Q26745946-8096C045-502B-4A17-BFE1-4868A6B3CCB0Q26747026-6A414470-54CB-471B-9546-F8C771FCBBBEQ26747475-9302DCDC-EE95-4FF6-92B0-0B5F1E59416FQ26798057-742741C7-5299-4CF6-9878-DCD151F1C998Q26864908-F5C1B1E1-D853-426D-BAD0-50DA270D4BCBQ27686781-D30874D8-FB8F-47E7-AA3D-25501B772F26Q28069946-4E9A1BE7-9084-4874-B0A7-888B290773B4Q28071340-4574ADBC-BA59-485B-BDCB-C42CA530DDA4Q28072836-1A8839A8-2706-4DE6-8821-A586A4EDA8ACQ28078517-67385727-BADF-4D28-846A-E0E4A57A3895Q28080258-D5F05BA1-F555-41AB-978D-D881517897A0Q28251391-FC0E0FF7-0B2F-4D10-B1C9-F257125DA067Q28677739-9325AE1A-14DB-48DD-A96D-147CF7BE7AFDQ28972330-D88F7C97-4A49-4D92-BD7E-BAF317AF75A3Q30251418-4476BF2F-2BF4-4548-9090-12C7D3D882C5Q33578422-AA72BAEA-36FD-4FD9-B4BB-61428DDEBB28Q33820362-B8F43EC0-E44D-4DF9-887C-E7A9A2CB749CQ34102651-D986E8FF-87DF-410B-BCB5-32FE4ED69A5EQ34250605-BD590EB7-C26F-47E2-8225-26D2B34B8525Q34256734-3E8BF838-AAAF-438F-97A6-FEF7190E4F4AQ34275388-2BF97266-40E3-4F6B-9771-A0D23D6D9B89Q34411741-3CD301F4-516B-4888-8145-673CB0F62B62Q34536010-56694B77-0D34-4879-9CA6-FD065CBE4668Q34536800-4F80881E-CF10-4149-8482-A067B5AFA41CQ34612912-4AD733DA-77A2-4CC3-836B-B08F8A54EC29Q34629651-06B86606-91F9-46F9-8C57-580A25E06830Q34632464-D33C450A-A958-453A-9D5D-7E5EEA2536EAQ34635830-9E770B2D-B4A7-42F4-B085-4B5837C28AB7Q34720816-3344B021-F35A-42CC-A7D8-4C31DABC1378Q34822757-BD56492F-B8E8-49F7-AB1D-134EB0B98BE0Q35050124-76889990-AA60-44F7-868D-489947982AE6Q35080572-6AE40F37-AF0E-4DBA-B413-DC62F2C37FA1Q35102695-2A365376-BE8C-4A1B-B7F2-CF4D571E622AQ35151307-1E7AE686-F6D2-407E-840C-234DBA796E16Q35563657-E6B78909-8D29-4620-B2AD-0F950AFEE5A0Q35756633-93BAC099-E4FC-48E1-A91F-E5E7A8431723Q35865078-27E7A105-D706-4612-9A45-C597883A6455Q35892876-B056F2BB-CAC4-4CBB-963D-3C35473C0891Q36047571-36A68570-0BBE-4A20-84BA-A4C577FAD64E
P2860
OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
OMEGA, a randomized, placebo-c ...... y after myocardial infarction.
@en
type
label
OMEGA, a randomized, placebo-c ...... y after myocardial infarction.
@en
prefLabel
OMEGA, a randomized, placebo-c ...... y after myocardial infarction.
@en
P2093
P921
P1433
P1476
OMEGA, a randomized, placebo-c ...... y after myocardial infarction.
@en
P2093
Bernhard Rauch
Frank Diller
Georg Sabin
Gerhard Steinbeck
Heinrich Worth
Helmut Gohlke
Hugo Katus
Jochen Senges
Martin Gottwik
Norbert Victor
P304
P356
10.1161/CIRCULATIONAHA.110.948562
P407
P577
2010-11-08T00:00:00Z